Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E M Langley

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Annals of the Royal College of Surgeons of England|September 30, 2006
Prostate cancer treatment. Permanent low-dose rate prostate brachytherapyStephen E M Langley
BJU International|May 31, 2020
Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experienceStephen E M Langley
BJU International|August 14, 2013
Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detectionSaqib Javed, Stephen E M Langley
BJU International|January 14, 2012
4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seedsStephen E M Langley, Robert W Laing
Brachytherapy|April 6, 2004
A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapyAlastair Henderson, Robert W Laing, Stephen E M Langley
Brachytherapy|April 6, 2004
Identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound techniqueAlastair Henderson, Robert W Laing, Stephen E M Langley
European Urology|January 22, 2004
Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A reviewAlastair Henderson, Robert W Laing, Stephen E M Langley
BJU International|September 13, 2005
Fertility after prostate brachytherapySara Jane Khaksar, Robert W Laing, Stephen E M Langley
BJU International|May 8, 2014
Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasiblePhilip Brousil, Muddassar Hussain, Mark Lynch, et al.
BJU International|September 22, 2011
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapyJenny P Nobes, Stephen E M Langley, Tanya Klopper, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Annals of the Royal College of Surgeons of England|September 30, 2006
Prostate cancer treatment. Permanent low-dose rate prostate brachytherapyStephen E M Langley
BJU International|May 31, 2020
Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experienceStephen E M Langley
BJU International|August 14, 2013
Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detectionSaqib Javed, Stephen E M Langley
BJU International|January 14, 2012
4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seedsStephen E M Langley, Robert W Laing
Brachytherapy|April 6, 2004
A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapyAlastair Henderson, Robert W Laing, Stephen E M Langley
Brachytherapy|April 6, 2004
Identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound techniqueAlastair Henderson, Robert W Laing, Stephen E M Langley
European Urology|January 22, 2004
Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A reviewAlastair Henderson, Robert W Laing, Stephen E M Langley
BJU International|September 13, 2005
Fertility after prostate brachytherapySara Jane Khaksar, Robert W Laing, Stephen E M Langley
BJU International|May 8, 2014
Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasiblePhilip Brousil, Muddassar Hussain, Mark Lynch, et al.
BJU International|September 22, 2011
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapyJenny P Nobes, Stephen E M Langley, Tanya Klopper, et al.
Pageof 3